Clovis Oncology (CLVS) Stock Value Declined While Venbio Select Advisor Has Boosted by $21.25 Million Its Holding; Chesapeake Energy (CHK) Shareholder Akanthos Capital Management Has Lifted Holding

April 21, 2018 - By mmahotstuff

Clovis Oncology, Inc. (NASDAQ:CLVS) Logo

Michael Kao increased its stake in Chesapeake Energy Corp (CHK) by 133.33% based on its latest 2017Q4 regulatory filing with the SEC. Akanthos Capital Management Llc bought 1.00 million shares as the company’s stock declined 23.38% with the market. The hedge fund run by Michael Kao held 1.75M shares of the oil & gas production company at the end of 2017Q4, valued at $6.93M, up from 750,000 at the end of the previous reported quarter. Akanthos Capital Management Llc who had been investing in Chesapeake Energy Corp for a number of months, seems to be bullish on the $2.69 billion market cap company. The stock decreased 0.99% or $0.03 during the last trading session, reaching $3. About 22.83 million shares traded. Chesapeake Energy Corporation (NYSE:CHK) has declined 42.83% since April 21, 2017 and is downtrending. It has underperformed by 54.38% the S&P500.

Venbio Select Advisor Llc increased its stake in Clovis Oncology Inc (CLVS) by 40.37% based on its latest 2017Q4 regulatory filing with the SEC. Venbio Select Advisor Llc bought 317,184 shares as the company’s stock declined 18.56% with the market. The institutional investor held 1.10 million shares of the health care company at the end of 2017Q4, valued at $75.00 million, up from 785,700 at the end of the previous reported quarter. Venbio Select Advisor Llc who had been investing in Clovis Oncology Inc for a number of months, seems to be bullish on the $2.54 billion market cap company. The stock decreased 2.24% or $1.15 during the last trading session, reaching $50.17. About 1.18 million shares traded. Clovis Oncology, Inc. (NASDAQ:CLVS) has declined 21.43% since April 21, 2017 and is downtrending. It has underperformed by 32.98% the S&P500.

Investors sentiment decreased to 1.04 in Q4 2017. Its down 0.21, from 1.25 in 2017Q3. It is negative, as 44 investors sold CHK shares while 110 reduced holdings. 50 funds opened positions while 110 raised stakes. 548.86 million shares or 4.62% less from 575.42 million shares in 2017Q3 were reported. Laurion Capital Mngmt LP has invested 0% in Chesapeake Energy Corporation (NYSE:CHK). Wealthtrust holds 900 shares or 0% of its portfolio. Kentucky Retirement Systems has 56,036 shares for 0.02% of their portfolio. Creative Planning owns 1.76M shares for 0.03% of their portfolio. Tsp Cap Mgmt Gru Ltd Liability holds 0.02% or 10,500 shares. Advantus Mngmt accumulated 91,553 shares or 0.01% of the stock. Jane Street Gru Limited Com reported 1.59 million shares. Alliancebernstein Lp reported 0% in Chesapeake Energy Corporation (NYSE:CHK). Raymond James & Associates holds 0% or 171,415 shares in its portfolio. State Treasurer State Of Michigan holds 266,370 shares. The Pennsylvania-based Susquehanna International Limited Liability Partnership has invested 0.01% in Chesapeake Energy Corporation (NYSE:CHK). United Capital Financial Advisers Ltd Liability Corp invested 0% in Chesapeake Energy Corporation (NYSE:CHK). Schneider Cap Mngmt reported 10.23 million shares stake. Mutual Of America Ltd holds 0% or 80,493 shares in its portfolio. Innovations Ltd Liability reported 0.78% of its portfolio in Chesapeake Energy Corporation (NYSE:CHK).

Among 33 analysts covering Chesapeake Energy Corporation (NYSE:CHK), 8 have Buy rating, 11 Sell and 14 Hold. Therefore 24% are positive. Chesapeake Energy Corporation had 97 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Chesapeake Energy Corporation (NYSE:CHK) earned “Underperform” rating by Bank of America on Thursday, May 11. The firm earned “Sell” rating on Friday, May 6 by UBS. The firm has “Underperform” rating by Jefferies given on Monday, October 9. The firm has “Hold” rating given on Wednesday, March 14 by Piper Jaffray. UBS maintained the stock with “Sell” rating in Friday, October 21 report. On Thursday, March 23 the stock rating was initiated by Stifel Nicolaus with “Buy”. Bank of America maintained Chesapeake Energy Corporation (NYSE:CHK) on Monday, May 15 with “Buy” rating. As per Tuesday, November 17, the company rating was downgraded by Sterne Agee CRT. The stock of Chesapeake Energy Corporation (NYSE:CHK) earned “Hold” rating by Tudor Pickering on Tuesday, April 12. Susquehanna maintained the stock with “Hold” rating in Monday, March 5 report.

Since December 15, 2017, it had 0 buys, and 7 sales for $1.64 million activity. SPICKSCHEN THORLEF also sold $270,090 worth of Clovis Oncology, Inc. (NASDAQ:CLVS) shares.

Venbio Select Advisor Llc, which manages about $380.08M and $1.54 billion US Long portfolio, decreased its stake in Veracyte Inc (NASDAQ:VCYT) by 184,454 shares to 752,455 shares, valued at $4.91 million in 2017Q4, according to the filing. It also reduced its holding in Medicines Co (NASDAQ:MDCO) by 423,833 shares in the quarter, leaving it with 1.30M shares, and cut its stake in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX).

Chesapeake Energy Corporation (NYSE:CHK) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>